Abstract:Abstract Background Endoscopic resection is the standard of care for the management of colorectal polyps. Larger and more complex polyps require endoscopic mucosal resection (EMR). While complications have been low, EMR is often piecemeal, resulting in indeterminant margins and often a higher recurrence rate. Endoscopic submucosal dissection (ESD) is an advanced endoscopic resection technique with a higher rate of en bloc resection. While more data exist for the resection of gastric lesions with ESD, ESD is becoming more widely used in western countries for the resection of colorectal lesions. Purpose The purpose of this study is to report on the outcomes and rates of complications for colorectal ESD completed in a tertiary centre in British Columbia. Method All colorectal ESD was completed by a senior therapeutic endoscopist who has previously received training in Japan. Retrospective data were collected on all colorectal ESD procedures done in St. Paul’s Hospital from July 11th, 2016, when the procedure first became available, to Aug 30th, 2022. Inclusion criteria were all adults who have undergone ESD for resection of a colorectal lesion. Exclusion criteria were patients younger than 18. Data collected included demographic variables, polyp characteristics, procedural outcomes, and complications. Result(s) A total of 39 ESD procedures were completed. The mean size of the resected lesion was 30.4 mm (range: 5 – 60 mm). Technical success, defined as successful resection of all polypoid tissue, was achieved in 35/39 procedures (89.7%). En-bloc resection was achieved in 27/35 (77.1%) of the completed ESD. The rate of R0 resection was 22/35 (62.9%). Curative resection, defined as technically successful ESD with R0 margin and no lymphovascular invasion, was achieved in 23/39 (59.0%) of the cases and the majority of the patients with non-curative resection that underwent endoscopic surveillance had no recurrence on follow-up. In our cohort, 3/39 (7.7%) patients had adenocarcinoma. None of the ESD resulted in any intra-procedural or delayed perforation. 3/39 (7.7%) patients had clinically significant post-endoscopic resection bleeding. Out of 24 patients that completed follow-up, 4 (16.7%) had recurrence at the resection site that was managed endoscopically. 4/39 (10.3%) of patients required surgery post-ESD. Conclusion(s) In our cohort, ESD is an effective endoscopic resection modality for the management of colorectal adenomas and early adenocarcinoma with a high rate of technical success and low rates of complications. Although the rate of curative resection was low, most were the result of R1 or Rx resection and a majority of the follow-ups in this subgroup demonstrated no further recurrence. The rate of en bloc resection is high, especially given the average size of adenomas in this cohort. Although ESD requires high technical proficiency, its favorable outcomes and low complication rates make ESD highly feasible for the resection of colorectal lesions. Please acknowledge all funding agencies by checking the applicable boxes below None Disclosure of Interest None Declared

Advanced Colon Cancer after Curative Resection of Intramucosal Adenocarcinoma with Endoscopic Submucosal Dissection

Metachronous Adenoma on Ileorectal Anastomosis Suture Line and Submucosal Deep Invasive Cancer Suspected of Rapid Growth in Rectal Remnant Following Long-Term Interval after Curative Surgery for Advanced Colon Cancer.

Curative ESD for Intraepithelial Esophageal Carcinoma with Leiomyoma Mimicking Submucosal Invasive Carcinoma

A case of early gastric cancer with metastatic recurrence following curative endoscopic submucosal dissection

Feasibility of Endoscopic Submucosal Dissection for Colorectal Neoplasia at Anastomotic Sites: a Retrospective Study

Long-term Outcomes of Endoscopic Submucosal Dissection for Colorectal Epithelial Neoplasms

A case of colon cancer implanted on endoscopic resection ulcer certified by cancer genomic testing

Patient outcomes after non-curative endoscopic submucosal dissection for early colorectal cancer: a single-center, retrospective cohort study

The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis.

Long-term outcomes of endoscopic submucosal dissection for high-grade dysplasia and early-stage carcinoma in the colorectum

Feasibility Of Endoscopic Submucosal Dissection For Colorectal Neoplasia In Anastomosis Site

Su1635 Efficacy of Endoscopic Submucosal Dissection for Colorectal T1 Cancer

Long-Term Follow-Up After Non-Curative Endoscopic Submucosal Dissection for Early Gastrointestinal Cancer—A Retrospective Multicenter Analysis

A131 ENDOSCOPIC SUBMUCOSAL DISSECTION OF COLORECTAL ADENOMAS AND EARLY ADENOCARCINOMAS: OUTCOMES FROM BRITISH COLUMBIA

Endoscopic submucosal dissection for superficial colorectal neoplasms: efficacyand risk factors for malignancy

Clinical outcome of non-curative endoscopic submucosal dissection for early colorectal cancer

Endoscopic Submucosal Dissection for Colorectal Epithelial Neoplasms with Submucosal Fibrosis

Clinicopathological Outcomes of Patients with Early Gastric Cancer after Non-Curative Endoscopic Submucosal Dissection

Efficacy and Safety of Endoscopic Submucosal Dissection for Colorectal Carcinoids.

Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis